Top Qs
Timeline
Chat
Perspective
AAVAnc80-hOTOF
Experimental gene therapy for a form of hearing loss From Wikipedia, the free encyclopedia
Remove ads
AAVAnc80-hOTOF is an experimental gene therapy for otoferlin gene-mediated hearing loss.[1][2]
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads